Lesions to the anterior hypothalamus prevent the melatonin-induced lengthening of delayed implantation.
The anterior hypothalamic area (AHA) has been postulated as a site of action for melatonin. We tested the hypothesis that lesions to the AHA (AHAx) would counteract the inhibitory effect of exogenous melatonin on blastocyst implantation in the spotted skunk by removing a possible site of action. Forty-seven females were treated as follows during delayed implantation. In Exp 1, five received empty Silastic capsules, five received Silastic capsules containing melatonin, six received sham AHAx plus empty capsules, none received AHAx plus empty capsules, and eight received AHAx plus capsules containing melatonin. In Exp 2, four skunks each received two empty capsules, five skunks each received two capsules containing melatonin, and five skunks received AHAx plus capsules containing melatonin. All capsules were inserted sc in the interscapular region 14-35 days after surgery in Exp 1 and 2 weeks before surgery in Exp 2. Surgery was performed between January 22 and February 12, 1988, in Exp 1 and on March 2-3, 1989, in Exp 2. The skunks were subjected to a natural photoperiod, and the duration of preimplantation was measured. In Exp 1, AHAx plus empty capsules significantly (P less than 0.05) shortened the duration of preimplantation (163 +/- 14.7 days) compared to that in sham AHAx or intact controls (193 +/- 26.1 and 188 +/- 10.6 days, respectively). Melatonin significantly (P less than 0.05) prolonged the duration of preimplantation (289 +/- 2.9 days) in intact skunks, but failed to do so in skunks with AHAx, as the preimplantation period was significantly shortened (159 +/- 6.1 days). In Exp 2, AHAx reversed the inhibitory effect of melatonin on the duration of preimplantation (191 +/- 21.5 days), as intact melatonin-treated skunks had a significantly longer preimplantation period (260 +/- 2.5 days) than skunks receiving empty capsules (191 +/- 16.4 days). The inhibitory effect of melatonin was reversible in all intact skunks, as blastocysts implanted 23 days, on the average, after cessation of treatment with melatonin. These data are consistent with the hypothesis that a portion of the AHA and/or adjacent regions play an essential role in timing blastocyst implantation in the spotted skunk. The lesions may have given this result by ablating a neural pathway controlling PRL secretion and may or may not have involved a site of action for melatonin.
Berria
M
M
Department of Biological Sciences, University of Idaho, Moscow 83843.
DeSantis
M
M
Mead
R A
RA
D000818:Animals; D001111:Arcuate Nucleus of Hypothalamus / Q000502:physiology; D002335:Carnivora / Q000502:physiology*; D010064:Embryo Implantation; D010065:Embryo Implantation, Delayed / Q000187:drug effects* / Q000502:physiology; D005260:Female; D007032:Hypothalamus, Anterior / Q000502:physiology* / Q000601:surgery; D008550:Melatonin / Q000494:pharmacology*; D012889:Mephitidae / Q000502:physiology*; D010286:Paraventricular Hypothalamic Nucleus / Q000502:physiology; D011247:Pregnancy; D013493:Suprachiasmatic Nucleus / Q000502:physiology; D014697:Ventromedial Hypothalamic Nucleus / Q000502:physiology
D008550:Melatonin